IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 112 filers reported holding IRADIMED CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEUTSCHE BANK AG\ | 3,414 | $162,984 | 0.00% |
| CITIGROUP INC | 2,175 | $103,835 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 19,962 | $952,986 | 0.00% |
| GOLDMAN SACHS GROUP INC | 46,967 | $2,242,205 | 0.00% |
| MORGAN STANLEY | 39,391 | $1,880,552 | 0.00% |
| Invesco Ltd. | 6,929 | $330,790 | 0.00% |
| AMALGAMATED BANK | 1,076 | $51 | 0.00% |
| Citadel Advisors | 33,877 | $1,617,288 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,303 | $635,085 | 0.00% |
| SIGNATUREFD, LLC | 3 | $143 | 0.00% |
| Tower Research Capital LLC (TRC) | 230 | $10,980 | 0.00% |
| ROYAL BANK OF CANADA | 487 | $23,000 | 0.00% |
External links
This page lists IRADIMED CORP's shareholders in Q2 2023. To view IRADIMED CORP's shareholder history, click here.